MD2935C2 - Utilizare a xenonului pentru tratamentul neurointoxicaţiilor - Google Patents

Utilizare a xenonului pentru tratamentul neurointoxicaţiilor Download PDF

Info

Publication number
MD2935C2
MD2935C2 MDA20010349A MD20010349A MD2935C2 MD 2935 C2 MD2935 C2 MD 2935C2 MD A20010349 A MDA20010349 A MD A20010349A MD 20010349 A MD20010349 A MD 20010349A MD 2935 C2 MD2935 C2 MD 2935C2
Authority
MD
Moldova
Prior art keywords
xenon
neurointoxications
treatment
neuromediators
caused
Prior art date
Application number
MDA20010349A
Other languages
English (en)
Russian (ru)
Other versions
MD2935B2 (ro
MD20010349A (ro
Inventor
Кристиан ПЕТЦЕЛТ
Вольфганг Й. КОКС
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7900688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD2935(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aga Ab filed Critical Aga Ab
Publication of MD20010349A publication Critical patent/MD20010349A/ro
Publication of MD2935B2 publication Critical patent/MD2935B2/ro
Publication of MD2935C2 publication Critical patent/MD2935C2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la medicină, şi anume la neurologie.În invenţie este descrisă utilizarea xenonului sau a amestecurilor gazoase conţinând xenon pentru tratamentul neurointoxicaţiilor. În particular, invenţia se referă la utilizarea xenonului în acele cazuri, când neurointoxicaţia este cauzată de un exces de neuromediatori. Xenonul poate reduce eliberarea neuromediatorilor, în primul rând a dopaminei, care este cauzată de condiţiile hipoxiei, cum ar fi apoplexia sau traumatismul craniocerebral.
MDA20010349A 1999-03-11 2000-03-08 Utilizare a xenonului pentru tratamentul neurointoxicaţiilor MD2935C2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19910986A DE19910986C2 (de) 1999-03-11 1999-03-11 Verwendung von Xenon bei der Behandlung von Neurointoxikationen
PCT/EP2000/002025 WO2000053192A1 (en) 1999-03-11 2000-03-08 Use of xenon for treating neurointoxications

Publications (3)

Publication Number Publication Date
MD20010349A MD20010349A (ro) 2002-02-28
MD2935B2 MD2935B2 (ro) 2005-12-31
MD2935C2 true MD2935C2 (ro) 2006-08-31

Family

ID=7900688

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010349A MD2935C2 (ro) 1999-03-11 2000-03-08 Utilizare a xenonului pentru tratamentul neurointoxicaţiilor

Country Status (29)

Country Link
US (3) US6559190B1 (ro)
EP (1) EP1158992B2 (ro)
JP (1) JP4954373B2 (ro)
KR (1) KR100674407B1 (ro)
CN (1) CN1170544C (ro)
AR (1) AR022886A1 (ro)
AT (1) ATE248599T1 (ro)
AU (1) AU757361B2 (ro)
BG (1) BG105889A (ro)
BR (1) BR0010456A (ro)
CA (1) CA2367136C (ro)
CZ (1) CZ302864B6 (ro)
DE (2) DE19910986C2 (ro)
DK (1) DK1158992T3 (ro)
EE (1) EE200100480A (ro)
ES (1) ES2206202T5 (ro)
HK (1) HK1048073B (ro)
HU (1) HUP0201393A3 (ro)
IL (2) IL145177A0 (ro)
MD (1) MD2935C2 (ro)
NO (1) NO20014379L (ro)
PL (1) PL202941B1 (ro)
PT (1) PT1158992E (ro)
RS (1) RS49756B (ro)
RU (1) RU2246949C2 (ro)
SI (1) SI1158992T1 (ro)
SK (1) SK285111B6 (ro)
WO (1) WO2000053192A1 (ro)
ZA (1) ZA200107291B (ro)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913677D0 (en) 1999-06-11 1999-08-11 Imperial College Formulation
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
DE10045829A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Volatile Anästhesiemittel mit Xenon
DE10054563A1 (de) * 2000-11-03 2002-05-16 Messer Griesheim Gmbh Verfahren und Vorrichtung zur Betonherstellung
AU2002220211A1 (en) * 2000-12-07 2002-06-18 Mclean Hospital Corporation Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
GB0210021D0 (en) 2002-05-01 2002-06-12 Air Prod & Chem Ultrasonic gas analyser
GB0209998D0 (en) † 2002-05-01 2002-06-12 Protexeon Ltd Use
DK1515732T3 (da) 2002-06-12 2009-05-11 Air Liquide Deutschland Gmbh Cerebral protektion med en xenonholdig gas
EP1521598A1 (de) * 2002-07-05 2005-04-13 Air Liquide Deutschland GmbH Xenon enthaltendes adjuvans
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
US7681572B2 (en) 2002-08-20 2010-03-23 Aga Ab Method and devices for administration of therapeutic gases
US7337776B2 (en) 2002-08-20 2008-03-04 Aga Ab Methods for easing pain and anxiety from atrial or ventricular defibrillation
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
PT1670489E (pt) * 2003-10-10 2008-02-28 Protexeon Ltd Utilização de xénon com hipotermia para o tratamento de asfixia neonatal
CA2542412A1 (en) * 2003-10-21 2005-05-06 Aga Ab Use of xenon for the prevention of programmed cell death
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1552840A1 (en) * 2004-01-07 2005-07-13 Aga Ab Use of a xenon/carbon monoxide mixture for the protection of cells
US7070005B2 (en) * 2004-02-10 2006-07-04 Planetair Turf Products, Llc Soil aerator assembly
EP1830856B1 (en) * 2004-08-02 2012-04-18 John W. Olney Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems
WO2007075100A1 (en) * 2005-12-27 2007-07-05 Zakrytoe Aktsionernoe Obshchestvo 'atom-Med Center' Method for treating drug dependence
EP1980260A1 (en) * 2007-04-10 2008-10-15 Nicholas Peter Franks Use of hyperbaric conditions to provide neuroprotection
WO2008132239A1 (en) 2007-04-30 2008-11-06 Nnoxe Pharmaceutiques Inc Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
WO2010035074A1 (en) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents
FR2952305B1 (fr) * 2009-11-10 2012-04-27 Air Liquide Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies
WO2011081612A1 (ru) * 2009-12-31 2011-07-07 Bondarenko Vitaliy Leonidovich Применение криптона или ксенона в качестве противовирусного средства
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2964036B1 (fr) 2010-08-24 2013-04-12 Air Liquide Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications
RU2583179C2 (ru) * 2011-02-07 2016-05-10 ЭДВАНСТ ПРЕЗЕРВЕЙШНЗ ТЕКНОЛОДЖИЗ, ЭлЭлСи Способ консервации клеток и культур клеток
FR2975597B1 (fr) * 2011-05-24 2013-12-27 Air Liquide Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes
RU2690450C2 (ru) 2011-09-26 2019-06-03 РИЧ ТЕКНОЛОДЖИЗ ХОЛДИНГ КОМПАНИ, ЭлЭлСи Способ консервации тромбоцитов
RU2489154C1 (ru) * 2012-05-31 2013-08-10 Сергей Александрович Наумов Способ лечения вирусных гепатитов
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
FR2996459B1 (fr) * 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996457B1 (fr) 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996458B1 (fr) * 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
PT2931291T (pt) 2012-12-11 2021-12-03 Mclean Hospital Corp Tratamento com xénon como complemento da psicoterapia para perturbações psiquiátricas
EP4082552A1 (en) 2013-03-15 2022-11-02 The Board of Regents of the University of Texas System Liquids rich in noble gas and methods of their preparation and use
FR3007983B1 (fr) * 2013-07-08 2015-06-26 Air Liquide Association de xenon et d'un antagoniste des recepteurs nmda pour lutter contre une maladie neurodegenerative
FR3022456B1 (fr) * 2014-06-20 2016-07-15 Air Liquide Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
FR3027226B1 (fr) * 2014-10-17 2017-12-08 L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude Medicament pour traiter une maladie liee a un dysfonctionnement de la transmission synaptique dopaminergique
CA2989432C (en) 2015-06-23 2022-08-09 Vlad BOGIN Therapeutic immune modulation using noble gas compositions
WO2017083373A1 (en) * 2015-11-09 2017-05-18 The Mclean Hospital Corporation Methods and compositions for the prevention of suicide, homicide and self-harming behaviors
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
US10485825B2 (en) * 2016-08-29 2019-11-26 Nobilis Therapeutics, Inc. Prevention of pregnancy complications by noble gas administration
EP3532073A4 (en) * 2016-10-31 2020-09-02 Nobilis Therapeutics, Inc. TREATMENT OF ANXIETY DISORDER AND INCREASED ANTI-ANXIETY INTERVENTIONS BY ADMINISTRATION OF MIXTURES CONTAINING A NOBLE GAS
CN107569509B (zh) * 2017-02-22 2018-09-21 滨州医学院 氙或氙气体混合物在制备治疗癫痫的制剂中的用途
CN108986622A (zh) * 2018-08-16 2018-12-11 广州迈普再生医学科技股份有限公司 一种颅内血肿微创穿刺清除术培训装置及其制备方法
RU2712804C1 (ru) * 2018-08-29 2020-01-31 Жовнерчук Инна Юрьевна Способ коррекции функционального состояния человека в замкнутом пространстве
RU2789964C1 (ru) * 2022-04-01 2023-02-14 Александр Юрьевич Верховский Способ улучшения состояния кожи и подкожных тканей

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864329B1 (de) * 1997-03-10 2000-12-13 Georgieff, Michael, Dr. Medizinische Präparation, die ein lipophiles Edelgas enthält

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
US5357959A (en) * 1993-04-16 1994-10-25 Praxair Technology, Inc. Altered dipole moment magnetic resonance imaging method
PT760819E (pt) * 1994-05-24 2000-11-30 Hoffmann La Roche Derivado dicarbonilicos triciclicos
RU2072241C1 (ru) * 1995-09-20 1997-01-27 Панина Елена Владимировна Способ формирования дыхательной газовой смеси и аппарат для его осуществления
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
IT1286058B1 (it) * 1996-10-29 1998-07-07 Siad Societa Italiana Acetilen Procedimento e apparecchiatura per la purificazione e recupero dello xeno e altri gas nobili in sistemi anestetici
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864329B1 (de) * 1997-03-10 2000-12-13 Georgieff, Michael, Dr. Medizinische Präparation, die ein lipophiles Edelgas enthält
EP0864328B1 (de) * 1997-03-10 2003-02-19 Michael Dr. Georgieff Vorrichtung zur gesteuerten Anästhesie, Analgesie und/oder Sedierung

Also Published As

Publication number Publication date
RU2246949C2 (ru) 2005-02-27
BR0010456A (pt) 2002-08-27
RS49756B (sr) 2008-04-04
CZ302864B6 (cs) 2011-12-21
PL350618A1 (en) 2003-01-27
KR20010108338A (ko) 2001-12-07
SI1158992T1 (en) 2004-02-29
ES2206202T5 (es) 2012-05-22
AR022886A1 (es) 2002-09-04
CA2367136A1 (en) 2000-09-14
EP1158992A1 (en) 2001-12-05
MD2935B2 (ro) 2005-12-31
DE60004974D1 (de) 2003-10-09
CN1359296A (zh) 2002-07-17
IL145177A0 (en) 2002-06-30
YU65401A (sh) 2004-07-15
BG105889A (bg) 2002-04-30
EP1158992B1 (en) 2003-09-03
DE60004974T2 (de) 2004-07-22
CZ20013234A3 (cs) 2002-06-12
MD20010349A (ro) 2002-02-28
HUP0201393A3 (en) 2002-10-28
ES2206202T3 (es) 2004-05-16
JP2002538209A (ja) 2002-11-12
ZA200107291B (en) 2003-02-26
DE60004974T3 (de) 2012-06-28
PL202941B1 (pl) 2009-08-31
US6559190B1 (en) 2003-05-06
CN1170544C (zh) 2004-10-13
EE200100480A (et) 2002-12-16
EP1158992B2 (en) 2012-02-01
CA2367136C (en) 2008-05-13
DK1158992T3 (da) 2003-12-29
NO20014379D0 (no) 2001-09-10
AU3287500A (en) 2000-09-28
KR100674407B1 (ko) 2007-01-26
DE19910986C2 (de) 2001-06-07
PT1158992E (pt) 2004-01-30
WO2000053192A1 (en) 2000-09-14
US8143317B2 (en) 2012-03-27
DE19910986A1 (de) 2000-09-21
US20070110821A1 (en) 2007-05-17
JP4954373B2 (ja) 2012-06-13
IL145177A (en) 2006-10-31
HK1048073A1 (en) 2003-03-21
NO20014379L (no) 2001-11-07
SK285111B6 (sk) 2006-06-01
HUP0201393A2 (en) 2002-09-28
HK1048073B (zh) 2005-06-03
US20030180375A1 (en) 2003-09-25
ATE248599T1 (de) 2003-09-15
AU757361B2 (en) 2003-02-20
SK12792001A3 (sk) 2002-07-02

Similar Documents

Publication Publication Date Title
MD2935C2 (ro) Utilizare a xenonului pentru tratamentul neurointoxicaţiilor
IL145213A0 (en) Polyurethane solutions containing allkoxysilane structural units
MX9700885A (es) Nuevas heteroariloxazolidinonas.
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
MY136520A (en) Novel compounds
GB0111186D0 (en) Novel compounds
MY135721A (en) Amidino compounds useful as nitric oxide synthase inhibitors
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
DK1200412T3 (da) Antiproliferative imidazolforbindelser
PL358004A1 (en) Pteridine compounds for the treatment of psoriasis
DE60112330D1 (en) Pyrazolopyridinderivate
PL374080A1 (en) Processes for the preparation of fibrinogen
MX2023010941A (es) Compuestos antibacterianos.
GR1004358B (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
MX2023014530A (es) Nitroxolina para su uso en el tratamiento de neurofibroma cutaneo.
WO2021214348A3 (de) Verbindungen für elektronische vorrichtungen
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MX2022003816A (es) Compuestos antibacterianos.
TW200700411A (en) Heterocyclylamide-substituted imidazoles
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
CY2183B1 (en) Antiprotozoal cyclic tetrapeptides
GB0025688D0 (en) Macrolides
MX2024001889A (es) Compuestos deuterados.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
PD4A Change of proprietorship (patent for invention)

Owner name: AIR PRODUCTS AND CHEMICALS, INC., US

Free format text: FORMER OWNER: AGA AB, SE; S-181 81 LIDINGO, SUEDIA

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees